Abstract
The possible membership of serous cavities of coelomic origin to the organs of the immune system is discussed. The participation of these serous cavities in the systematic regulation of inflammation and immunity is considered. The role of serous cavities under study in the pathogenesis of haemopietic tissue tumors, autoimmune diseases, and conditions that are manifestations of a “cytokine storm” is also discussed. The role of serous cavities of coelomic origin as potential therapeutic targets in these diseases and pathological conditions is considered.
Similar content being viewed by others
References
Abo, T., Tomiyama, C., and Watanabe, H., Biology of autoreactive extrathymic T cells and B-1 cells of the innate immune system, Immunol. Res., 2012, vol. 52, no. 3, pp. 224–230.
Andreu-Sánchez, J.L., de Alborán, I.M., Marcos, M.A.R., et al., Interleukin 2 abrogates the nonresponsive state of T cells expressing a forbidden T cell receptor repertoire and induces autoimmune disease in neonatally thymectomized mice, J. Exp. Med., 1991, vol. 173, no. 6, pp. 1323–1329.
Attanoos, R., Lymphoproliferative conditions of the serosa, Arch. Pathol. Lab. Med., 2012, vol. 136, no. 3, pp. 268–276.
Barbeiro, D.F., Barbeiro, H.V., Faintuch, J., et al., B-1 cells temper endotoxemic inflammatory responses, Immunobiology, 2011, vol. 216, no. 3, pp. 302–308.
Behrens, E.M., Canna, S.W., Slade, K., et al., Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice, J. Clin. Invest., 2011, vol. 121, no. 6, pp. 2264–2277.
Berberich, S., Förster, R., and Pabst, O., The peritoneal micromilieu commits B-cells to home to body cavities and the small intestine, Blood, 2007, vol. 109, no. 11, pp. 4627–4634.
Bhaumik, S., Mitra, R., Varalakshmi, C., and Khar, A., Activated macrophages migrate to the subcutaneous tumor site via the peritoneum: a novel route of cell trafficking, Exp. Cell. Res., 2001, vol. 266, no. 1, pp. 44–52.
Bichi, R., Shinton, S.A., Martin, E.S., et al., Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression, Proc. Natl. Acad. Sci. U.S.A., 2002, vol. 99, no. 10, pp. 6955–6960.
Busse, M., Traeger, T., Pötschke, C., et al., Detrimental role for CD4+ T-lymphocytes in murine diffuse peritonitis due to inhibition of local bacterial elimination, Gut, 2008, vol. 57, no. 2, pp. 188–195.
Calabró, M.L., Gasperini, P., Di Gangi, I.M., et al., Antineoplastic activity of lentiviral vectors expressing interferon-alpha in a preclinical model of primary effusion lymphoma, Blood, 2009, vol. 113, no. 19, pp. 4525–4533.
Carbone, F.R., Mackay, L.K., Heath, W.R., and Gebhardt, T., Distinct resident and re-circulating memory T cell subsets in non-lymphoid tissues, Curr. Opin. Immunol., 2013, vol. 25, no. 3, pp. 329–333.
Casey, S.C., Nelson, E.L., Turco, G.M., et al., B-1 cell lymphoma in mice lacking the steroid and xenobiotic receptor, SXR, Mol. Endocrinol., 2011, vol. 25, no. 6, pp. 933–943.
Composto, G., Gonzalez, D., Bucknum, A., et al., Peritoneal T lymphocyte regulation by macrophages, Immunobiology, 2011, vol. 216, nos. 1–2, pp. 256–264.
Crysandt, M., Neumann, B., Das, M., et al., Intraperitoneal application of rituximab in refractory mantle cell lymphoma with massive ascites resulting in local and systemic response, Eur. J. Haematol., 2007, vol. 79, no. 6, pp. 546–549.
Das, D.K., Serous effusions in malignant lymphomas: a review, Diagn. Cytopathol., 2006, vol. 43, no. 5, pp. 335–347.
Ding, B.B., Yu, J.J., Yu, R.Y., et al., Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas, Blood, 2008, vol. 111, no. 3, pp. 1515–1523.
Du, M.Q., Bacon, C.M., and Isaacson, P.G., Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 and lymphoproliferative disorders, J. Clin. Pathol., 2007, vol. 60, no. 12, pp. 1350–1357.
Eddou, H., El Bouzidi, A., Valero, E., et al., Primary granulocytic sarcoma of the peritoneum: a case report and literature review, Ann. Biol. Clin., 2012, vol. 70, no. 1, pp. 93–97.
Grivennikov, S. and Karin, M., Dangerous liaisons: STAT3 and NF-kB collaboration and crosstalk in cancer, Cytokine Growth Factor Rev., 2010, vol. 21, no. 1, pp. 11–19.
Guastafierro, S., Falcone, U., Celentano, M., et al., Chronic lymphocytic leukemia presenting with symptomatic peritoneal infiltration, Leuk. Res., 2010, vol. 34, no. 4, p. e115–116.
Hamaguchi, Y., Uchida, J., Cain, D.W., et al., The peritoneal cavity provides a protective niche for B-1 and conventional B-lymphocytes during anti-CD20 immunotherapy in mice, J. Immunol., 2005, vol. 174, no. 7, pp. 4389–4399.
Hausmann, M.J., Rogachev, B., Weiler, M., et al., Accessory role of human peritoneal mesothelial cells in antigen presentation and T-cell growth, Kidney Int., 2000, vol. 57, no. 2, pp. 476–486.
Herington, J.L., Bruner-Tran, K.L., Lucas, J.A., and Osteen, K.G., Immune interactions in endometriosis, Expert Rev. Clin. Immunol., 2011, vol. 7, no. 5, pp. 611–626.
Hiroshima, Y., Tajima, K., Shiono, Y., et al., Rituximab pharmacokinetics in ascites and serum in the treatment of follicular lymphoma with massive ascites, Ann. Hematol., 2012, vol. 91, no. 9, pp. 1499–1500.
Huo, Y., Zhao, L., Hyman, M.C., et al., Critical role of macrophage 12/15-lipoxygenase for atherosclerosis in apolipoprotein E-deficient mice, Circulation, 2004, vol. 110, no. 14, pp. 2024–2031.
Jiang, A.G., Yang, Y.T., Gao, X.Y., and Lu, H.Y., Bilateral pleural effusion as an initial manifestation of multiple myeloma: a case report and literature review, Exp. Ther. Med., 2015, vol. 9, no. 3, pp. 1040–1042.
Jung, S.H., Kim, H.C., Yu, C.S., and Kim, J.C., Solitary preleukemic granulocytic sarcoma as a cause of small bowel obstruction, Gut Liver, 2007, vol. 1, no. 1, pp. 82–86.
Kapoor, V.N., Kang, J., and Welsh, R.M., Regulation of tissue-dependent differences in CD8+ T cell apoptosis during viral infection, J. Virol., 2014, vol. 88, no. 17, pp. 9490–9503.
Kawada, H., Fukuda, R., Suzuki, M., et al., Unusual relapse of adult T-cell leukemia/lymphoma after spontaneous remission, Leuk. Res., 1998, vol. 22, no. 2, pp. 197–199.
Kendall, P.L., Woodward, E.J., Hulbert, C., and Thomas, J.W., Peritoneal B cells govern the outcome of diabetes in non-obese diabetic mice, Eur. J. Immunol., 2004, vol. 34, no. 9, pp. 2387–2395.
Kilari, D., Venci, N., Friedberg, J., and Bennett, J.M., Hemophagocytic lymphohistiocytosis masquerading as progressive chronic lymphocytic leukemia, Leuk. Res. Rep., 2013, vol. 2, no. 1, pp. 4–6.
Kitayama, J., Emoto, S., Yamaguchi, H., et al., CD90+ mesothelial-like cells in peritoneal fluid promote peritoneal metastasis by forming a tumor permissive microenvironment, PLoS One, 2014a, vol. 9, no. 1, p. e86516.
Kitayama, J., Emoto, S., Yamaguchi, H., et al., CD90+CD45–intraperitoneal mesothelial-like cells inhibit T cell activation by production of arginase I, Cell. Immunol., 2014b, vol. 288, nos. 1–2, pp. 8–14.
Lábadi, Á. and Balogh, P., Differential preferences in serosal homing and distribution of peritoneal B-cell subsets revealed by in situ CFSE labeling, Int. Immunol., 2009, vol. 21, no. 9, pp. 1047–1056.
Li, J., Zhang, Y., Lou, J., et al., Neutralization of peritoneal IL-17A markedly improves the prognosis of severe septic mice by decreasing neutrophil infiltration and proinflammatory cytokines, PLoS One, 2012, vol. 7, no. 10, p. e46506.
Lignitto, L., Mattiolo, A., Negri, E., et al., Crosstalk between the mesothelium and lymphomatous cells: insight into the mechanisms involved in the progression of body cavity lymphomas, Cancer Med., 2014, vol. 3, no. 1, pp. 1–3.
Liu, Y., Deng, J., Wang, L., et al., S1PR1 is an effective target to block STAT3 signaling in activated B-cell-like diffuse large B-cell lymphoma, Blood, 2012, vol. 120, no. 7, pp. 1458–1465.
Ma, S., Shukla, V., Fang, L., et al., Accelerated development of chronic lymphocytic leukemia in New Zealand Black mice expressing a low level of interferon regulatory factor 4, J. Biol. Chem., 2013, vol. 288, no. 37, pp. 26430–26440.
Makhonova, L.A., Histiocytic diseases, in Klinicheskie lektsii po detskoi onkologii (Clinical Lecturers on Child Oncology), Moscow: Med. Inf. Agentstvo, 2006, part 2, pp. 94–109.
Margry, B., Kersemakers, S.C.W., Hoek, A., et al., Activated peritoneal cavity B-1a cells possess regulatory B cell properties, PLoS One, 2014, vol. 9, no. 2, p. e88869.
Matlack, R., Yeh, K., Rosini, L., et al., Peritoneal macrophages suppress T-cell activation by amino acid catabolism, Immunology, 2006, vol. 117, no. 3, pp. 386–395.
Mitra, R., Dharajiya, N., Kumari, L., et al., Migration of antigen presenting cells from periphery to the peritoneum during an inflammatory response: role of chemokines and cytokines, FASEB J., 2004, vol. 18, no. 14, pp. 1764–1766.
Miyakawa, R., Miyaji, C., Watanabe, H., et al., Unconventional NK1.1(–) intermediate TCR cells as major T lymphocytes expanding in chronic graft-versus-host disease, Eur. J. Immunol., 2002, vol. 32, no. 9, pp. 2521–2531.
Mueller, B.U., Buerger, A.U., Solenthaler, M., et al., Pleural tumors as sole primary manifestation of acute promyelocytic leukemia, Ann. Oncol., 2006, vol. 17, no. 4, pp. 722–723.
Murakami, M. and Honjo, T., Anti-red blood cell autoantibody transgenic mice: murine model of autoimmune hemolytic anemia, Semin. Immunol., 1996, vol. 8, no. 1, pp. 3–9.
Murakami, M., Yoshioka, H., Shirai, T., et al., Prevention of autoimmune symptoms in autoimmune-prone mice by elimination of B-1 cells, Int. Immunol., 1995, vol. 7, no. 5, pp. 877–882.
Nakatani, T., Shinohara, H., Fukuo, Y., et al., Pericardium of rodents: pores connect the pericardial and pleural cavities, Anat. Rec., 1988, vol. 220, no. 2, pp. 132–137.
Ngo, V.N., Korner, H., Gunn, M.D., et al., Lymphotoxin alpha/beta and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen, J. Exp. Med., 1999, vol. 189, no. 2, pp. 403–412.
Oral, E., Olive, D.L., and Arici, A., The peritoneal environment in endometriosis, Hum. Reprod. Update, 1996, vol. 2, no. 5, pp. 385–398.
Otero, D.C., Poli, V., David, M., and Rickert, R.C., Cutting edge: inherent and acquired resistance to radiation-induced apoptosis in B cells: a pivotal role for STAT3, J. Immunol., 2006, vol. 177, no. 10, pp. 6593–6597.
Parungo, C.P., Soybel, D.J., Colson, Y.L., et al., Lymphatic drainage of the peritoneal space: a pattern dependent on bowel lymphatics, Ann. Surg. Oncol., 2007, vol. 14, no. 2, pp. 286–298.
Prado-Garcia, H., Romero-Garcia, S., Morales-Fuentes, J., et al., Activation-induced cell death of memory CD8+ T cells from pleural effusion of lung cancer patients is mediated by the type IIFas-induced apoptotic pathway, Cancer Immunol. Immunother., 2012, vol. 61, no. 7, pp. 1065–1080.
Rauch, P.J., Chudnovskiy, A., Robbins, C.S., et al., Innate response activator B cells protect against microbial sepsis, Science, 2012, vol. 335, no. 6068, pp. 597–601.
Relvas, W.G., Izar, M.C., Segreto, H.R., et al., Resident peritoneal inflammatory cells are pivotal in the development of experimental atherosclerosis, J. Atheroscler. Thromb., 2010, vol. 17, no. 4, pp. 378–385.
Roberts, G.W., Baird, D., Gallagher, K., et al., Functional effector memory T cells enrich the peritoneal cavity of patients treated with peritoneal dialysis, J. Am. Soc. Nephrol., 2009, vol. 20, no. 9, pp. 1895–1900.
Rodriguez-Manzanet, R., Sanjuan, M., Wu, H.Y., et al., T and B cell hyperactivity and autoimmunity associated with niche-specific defects in apoptotic body clearance in TIM-4-deficient mice, Proc. Natl. Acad. Sci. U.S.A., 2010, vol. 107, no. 19, pp. 8706–8711.
Rosini, L., Matlack, R., Taylor, J., et al., Nonlymphoid peritoneal cells suppress the T cell response to Mls, Immunobiology, 2004, vol. 209, no. 8, pp. 575–584.
Sammour, T., Kahokehr, A., Soop, M., and Hill, A.G., Peritoneal damage: the inflammatory response and clinical implications of the neuro-immuno-humoral axis, World J. Surg., 2010, vol. 34, no. 4, pp. 704–720.
Schenkel, J.M., Fraser, K.A., Vezys, V., and Masopust, D., Sensing and alarm function of resident memory CD8+ T cells, Nat. Immunol., 2013, vol. 14, no. 5, pp. 509–513.
Scherpereel, A., Grigoriu, B.D., Noppen, M., et al., Defect in recruiting effector memory CD8+ T-cells in malignant pleural effusions compared to normal pleural fluid, BMC Cancer, 2013, vol. 13, p. 324.
Schmidt, H.H., Renner, H., and Linkesch, W., Intrapleural instillation of rituximab for the treatment of malignant pleural effusions in NHL, Haematologica, 2004, vol. 89, no. 11, p. ECR39.
Shukla, V., Ma, S., Hardy, R.R., et al., A role for IRF4 in the development of CLL, Blood, 2013, vol. 122, no. 16, pp. 2848–2855.
Silberman, D., Bucknum, A., Kozlowski, M., et al., Cytokine treatment of macrophage suppression of T cell activation, Immunobiology, 2010, vol. 215, no. 1, pp. 70–80.
Stall, A.M., Farinas, M.C., Tarlinton, D.M., et al., Ly-1 B-cell clones similar to human chronic lymphocytic leukemias routinely develop in older normal mice and young autoimmune (New Zealand Black-related) animals, Proc. Natl. Acad. Sci. U.S.A., 1988, vol. 85, no. 19, pp. 7312–7316.
Stevceva, L., Moniuszko, M., and Ferrari, M.G., Utilizing IL-12, IL-15 and IL-7 as mucosal vaccine adjuvants, Lett. Drug Des. Discovery, 2006, vol. 3, no. 8, pp. 586–592.
Tamang, D.L., Alves, B.N., Elliott, V., et al., Low dose IL-15 induces snap arming of CD44low T lymphocytes in the absence of antigen, Cell. Immunol., 2008, vol. 251, no. 2, pp. 93–101.
Umezawa, K., Possible role of peritoneal NF-kB in peripheral inflammation and cancer: lesions from the inhibitor DHMEQ, Biomed. Pharmacother., 2011, vol. 65, no. 4, pp. 252–259.
Valle, M.T., Degl’Innocenti, M.L., Bertelli, R., et al., Antigen-presenting function of human peritoneum mesothelial cells, Clin. Exp. Immunol., 1995, vol. 101, no. 1, pp. 172–176.
von Moltke, J., Trinidad, N.J., Moayeri, M., et al., Rapid induction of inflammatory lipid mediators by the inflammasome in vivo, Nature, 2012, vol. 490, no. 7418, pp. 107–111.
Watanabe, T., Kawamura, T., Kawamura, H., et al., Intermediate TCR cells in mouse lung: their effector function to induce pneumonitis in mice with autoimmunelike graft-versus-host disease, J. Immunol., 1997, vol. 158, no. 12, pp. 5805–5814.
Weerasinghe, A., Kawamura, T., Moroda, T., et al., Intermediate TCR cells can induce graft-versus-host disease after allogeneic bone marrow transplantation, Cell. Immunol., 1998, vol. 158, no. 12, pp. 5805–5814.
Wong, J.W., Pitlik, D., and Abdul-Karim, F.W., Cytology of pleural, peritoneal and pericardial fluids in children. A 40-year summary, Acta Cytol., 1997, vol. 41, no. 2, pp. 467–473.
Wu, J., IL-15 agonists: the cancer cure cytokine, J. Mol. Genet. Med., 2013, vol. 7, p. 85.
Wu, Q., Wang, Y., Wang, J., et al., The requirement of membrane lymphotoxin for the presence of dendritic cells in lymphoid tissues, J. Exp. Med., 1999, vol. 190, no. 5, pp. 629–638.
Yonal, I., Ciftcibasi, A., Gokturk, S., et al., Massive ascites as the initial manifestation of mantle cell lymphoma: a challenge for the gastroenterologist, Case Rep. Gastroenterol., 2012, vol. 6, no. 3, pp. 803–809.
Yoneda, A., Ito, S., Susumu, S., et al., Immunological milieu in the peritoneal cavity at laparotomy for gastric cancer, World J. Gasrtoenterol., 2012, vol. 18, no. 13, pp. 1470–1478.
Yoshida, R., Imai, T., Hieshima, K., et al., Molecular cloning of a novel human CCchemokine EBI1-ligand chemokine that is a specific functional ligand for EBI1, CCR7, J. Biol. Chem., 1997, vol. 272, no. 21, pp. 13803–13809.
Zhang, L.L., Li, Y.Y., Hu, C.P., and Yang, H.P., Myelomatous pleural effusion as an initial sign of multiple myeloma—a case report and review of literature, J. Thorac. Dis., 2014, vol. 6, no. 7, pp. 152–159.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © I.V. Ganshina, 2016, published in Uspekhi Sovremennoi Biologii, 2016, Vol. 136, No. 4, pp. 335–346.
Rights and permissions
About this article
Cite this article
Ganshina, I.V. Serous cavities of coelomic origin as possible organs of the immune system. Part 2. Biol Bull Rev 7, 129–138 (2017). https://doi.org/10.1134/S2079086417020037
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S2079086417020037